PLRG1 Antikörper
(1 reference)-
- Target Alle PLRG1 Antikörper anzeigen
- PLRG1 (Pleiotropic Regulator 1 (PLRG1))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PLRG1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Goat polyclonal antibody raised against synthetic peptide of PLRG1.
- Sequenz
- C-PVSWKPEIIK RKRF
- Kreuzreaktivität
- Human, Maus, Ratte
- Produktmerkmale
- Antibody Reactive Against Synthetic Peptide.
- Immunogen
- A synthetic peptide corresponding to human PLRG1.
- Top Product
- Discover our top product PLRG1 Primärantikörper
-
anti-Pleiotropic Regulator 1 (PLRG1) (AA 101-198) antibody
PLRG1 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 7H2 unconjugated
anti-Pleiotropic Regulator 1 (PLRG1) (C-Term) antibodyPLRG1 Reaktivität: Human WB, IF, IHC (p), ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Pleiotropic Regulator 1 (PLRG1) (C-Term) antibodyVerified PLRG1 Reaktivität: Human, Maus WB, ELISA, IHC Wirt: Ziege Polyclonal unconjugated
anti-Pleiotropic Regulator 1 (PLRG1) (AA 17-45), (N-Term) antibodyPLRG1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB36131 unconjugated
anti-Pleiotropic Regulator 1 (PLRG1) (AA 52-101) antibodyPLRG1 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Kaninchen, Meerschweinchen, Affe WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
ELISA (1:16000)
Western blot (0.5-2 μg/mL)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- In Tris saline, pH 7.3 (0.5 % BSA, 0.02 % sodium azide)
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
-
Store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
: "Identification of peptide inhibitors of pre-mRNA splicing derived from the essential interaction domains of CDC5L and PLRG1." in: Nucleic acids research, Vol. 31, Issue 21, pp. 6104-16, (2003) (PubMed).
-
: "Identification of peptide inhibitors of pre-mRNA splicing derived from the essential interaction domains of CDC5L and PLRG1." in: Nucleic acids research, Vol. 31, Issue 21, pp. 6104-16, (2003) (PubMed).
-
- Target
- PLRG1 (Pleiotropic Regulator 1 (PLRG1))
- Andere Bezeichnung
- PLRG1 (PLRG1 Produkte)
- Synonyme
- wu:fi74f01 antikoerper, zgc:55651 antikoerper, zgc:86603 antikoerper, NV13087 antikoerper, Cwc1 antikoerper, PRL1 antikoerper, PRP46 antikoerper, PRPF46 antikoerper, TANGO4 antikoerper, AA958940 antikoerper, C80566 antikoerper, Tango4 antikoerper, pleiotropic regulator 1 antikoerper, cgd7_3960 antikoerper, Chro.70442 antikoerper, CpipJ_CPIJ004561 antikoerper, Tsp_06269 antikoerper, plrg1 antikoerper, LOC100115457 antikoerper, PLRG1 antikoerper, Plrg1 antikoerper
- Gen-ID
- 5356
-
